Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-03-26 4:30 pm Purchase | 13G | BIOMX INC PHGE | Cystic Fibrosis Foundation | 9,330,580 15.6% | 4,778,265 (+104.96%) | View |
| 2024-03-25 3:35 pm Purchase | 13G | BIOMX INC PHGE | AMR Action Fund L.P. | 3,054,870 5.5% | 3,054,870 (New Position) | View |
| 2024-03-22 5:44 pm Purchase | 13D | BIOMX INC PHGE | Flynn James E | 6,110,098 11.06% | 6,110,098 (New Position) | View |
| 2024-03-19 9:11 pm Purchase | 13D | BIOMX INC PHGE | OrbiMed Israel BioFund GP Limited Partnership | 12,577,821 19.9% | 7,976,013 (+173.32%) | View |
| 2024-03-08 4:30 pm Purchase | 13D | BIOMX INC PHGE | OrbiMed Israel BioFund GP Limited Partnership | 4,601,808 9.9% | 48,319 (+1.06%) | View |
| 2024-02-13 1:09 pm Sale | 13G | BIOMX INC PHGE | MMCAP International Inc. SPC | 1,527,994 3.22% | -694,887 (-31.26%) | View |
| 2024-02-02 5:07 pm Sale | 13G | BIOMX INC PHGE | JOHNSON & JOHNSON JNJ | 2,113,402 4.6% | -20,000 (-0.94%) | View |
| 2024-01-30 4:05 pm Purchase | 13G | BIOMX INC PHGE | Cystic Fibrosis Foundation | 4,552,315 9.9% | 1,801,327 (+65.48%) | View |
| 2023-09-29 09:20 am Purchase | 13G | BIOMX INC PHGE | Centaurus Investments Ltd | 2,839,714 6.2% | 2,839,714 (New Position) | View |
| 2023-06-23 4:50 pm Purchase | 13G | BIOMX INC PHGE | Burbank John Howard III | 4,598,189 9.99% | 4,598,189 (New Position) | View |
| 2023-05-08 4:43 pm Purchase | 13D | BIOMX INC PHGE | OrbiMed Israel BioFund GP Limited Partnership | 4,553,489 9.9% | 1,017,000 (+28.76%) | View |
| 2023-03-17 4:19 pm Purchase | 13D | BIOMX INC PHGE | OrbiMed Israel BioFund GP Limited Partnership | 3,536,489 10.5% | 1,245,999 (+54.40%) | View |
| 2023-03-08 5:22 pm Purchase | 13G | BIOMX INC PHGE | Cystic Fibrosis Foundation | 2,750,988 8.1% | 2,750,988 (New Position) | View |
| 2023-02-14 12:53 pm Purchase | 13G | BIOMX INC PHGE | MMCAP International Inc. SPC | 2,222,881 7.08% | 107,242 (+5.07%) | View |
| 2023-02-13 3:57 pm Sale | 13G | BIOMX INC PHGE | Ugwumba Chidozie | 922,800 3.07% | -2,074,225 (-69.21%) | View |
| 2022-11-14 5:10 pm Sale | 13G | BIOMX INC PHGE | Ugwumba Chidozie | 2,997,025 9.99% | -2,515,821 (-45.64%) | View |
| 2022-08-04 7:59 pm Unchanged | 13G | BIOMX INC PHGE | TAKEDA PHARMACEUTICAL CO LTD TAK | 1,478,286 4.96% | 0 (Unchanged) | View |
| 2022-02-14 4:09 pm Sale | 13G | BIOMX INC PHGE | Walton Thomas Layton | 0 0% | -5,512,846 (Position Closed) | View |
| 2022-02-14 3:49 pm Purchase | 13G | BIOMX INC PHGE | Ugwumba Chidozie | 5,512,846 19.28% | 5,512,846 (New Position) | View |
| 2022-02-03 8:37 pm Purchase | 13G | BIOMX INC PHGE | MMCAP International Inc. SPC | 2,115,639 7.5% | 715,594 (+51.11%) | View |